Results 1 to 10 of about 2,447,849 (285)

Opioid Receptors in Immune and Glial Cells—Implications for Pain Control

open access: yesFrontiers in Immunology, 2020
Opioid receptors comprise μ (MOP), δ (DOP), κ (KOP), and nociceptin/orphanin FQ (NOP) receptors. Opioids are agonists of MOP, DOP, and KOP receptors, whereas nociceptin/orphanin FQ (N/OFQ) is an agonist of NOP receptors.
Halina Machelska, Melih Ö. Celik
doaj   +2 more sources

Historical Review: Opiate Addiction and Opioid Receptors

open access: yesCell Transplantation, 2019
Substance use disorders (SUDs), defined as a collection of symptoms including tolerance and withdrawal, are chronic illnesses characterized by relapse and remission. In the United States, billions of dollars have been lost due to SUDs.
Shaocheng Wang
doaj   +2 more sources

Opioid Receptor-Mediated Regulation of Neurotransmission in the Brain

open access: yesFrontiers in Molecular Neuroscience, 2022
Opioids mediate their effects via opioid receptors: mu, delta, and kappa. At the neuronal level, opioid receptors are generally inhibitory, presynaptically reducing neurotransmitter release and postsynaptically hyperpolarizing neurons.
Kaitlin C. Reeves   +6 more
doaj   +2 more sources

Opioid Receptors

open access: yesAnnual Review of Medicine, 2016
Opioids are the oldest and most potent drugs for the treatment of severe pain. Their clinical application is undisputed in acute (e.g., postoperative) and cancer pain, but their long-term use in chronic pain has met increasing scrutiny. This article reviews mechanisms underlying opioid analgesia and other opioid actions.
C. Stein
openaire   +3 more sources

A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain

open access: yesPain and Therapy, 2020
Buprenorphine is a Schedule III opioid analgesic with unique pharmacodynamic and pharmacokinetic properties that may be preferable to those of Schedule II full μ-opioid receptor agonists.
Jeffrey Gudin, Jeffrey Fudin
doaj   +2 more sources

Targeting peripheral opioid receptors to promote analgesic and anti-inflammatory actions

open access: yesFrontiers in Pharmacology, 2013
Mechanisms of endogenous pain control are significant. Increasing studies have clearly produced evidence for the clinical usefulness of opioids in peripheral analgesia.
Katerina eIwaszkiewicz   +2 more
doaj   +2 more sources

Opioids and opioid receptors; understanding pharmacological mechanisms as a key to therapeutic advances and mitigation of the misuse crisis [PDF]

open access: yesBJA Open, 2023
Opioids are a mainstay in acute pain management and produce their effects and side effects (e.g., tolerance, opioid-use disorder and immune suppression) by interaction with opioid receptors.
David G. Lambert
doaj   +2 more sources

Selective targeting of mu opioid receptors to primary cilia [PDF]

open access: yesCell Reports
Summary: Opioid receptors are therapeutically important G protein-coupled receptors (GPCRs) with diverse neuromodulatory effects. The functional consequences of opioid receptor activation are known to depend on receptor location in the plasma membrane ...
Rita R. Fagan   +5 more
doaj   +2 more sources

Biased ligands at opioid receptors: Current status and future directions

open access: yesScience Signaling, 2021
Ongoing efforts to identify and characterize biased ligands for opioid receptors are discussed. The opioid crisis represents a major worldwide public health crisis that has accelerated the search for safer and more effective opioids.
T. Che   +3 more
semanticscholar   +1 more source

Biased, Bitopic, Opioid–Adrenergic Tethered Compounds May Improve Specificity, Lower Dosage and Enhance Agonist or Antagonist Function with Reduced Risk of Tolerance and Addiction

open access: yesPharmaceuticals, 2022
This paper proposes the design of combination opioid–adrenergic tethered compounds to enhance efficacy and specificity, lower dosage, increase duration of activity, decrease side effects, and reduce risk of developing tolerance and/or addiction ...
Robert Root-Bernstein
doaj   +1 more source

Home - About - Disclaimer - Privacy